Celcuity Inc. operates as a cellular analysis company that discovers new cancer sub-types and commercializes diagnostic tests. The Company designs technology that uses a patient's living tumor cells to identify the specific abnormal cellular process to treat cancer patients. Celcuity serves patients in the United States.